Buying 500 shares of Daiichi Sankyo stock 16 days before the company signed a lucrative licensing deal with AstraZeneca has a former AZ executive in the Securities and Exchange Commission's (SEC's) crosshairs. According to an SEC complaint, Hugues Joublin, Ph.D.—who was AZ’s global head of corporate affairs for oncology—has been charged with taking advantage of his advance knowledge of the 2019 deal to buy $20,000 worth of stock. Joublin became aware of AZ’s impending deal to acquire commercial rights to Daiichi Sankyo’s breast cancer drug Enhertu on March 6, 2019, the filing alleges; six...…Buying 500 shares of Daiichi Sankyo stock 16 days before the company signed a lucrative licensing deal with AstraZeneca has a former AZ executive in the Securities and Exchange Commission's (SEC's) crosshairs. According to an SEC complaint, Hugues Joublin, Ph.D.—who was AZ’s global head of corporate affairs for oncology—has been charged with taking advantage of his advance knowledge of the 2019 deal to buy $20,000 worth of stock. Joublin became aware of AZ’s impending deal to acquire commercial rights to Daiichi Sankyo’s breast cancer drug Enhertu on March 6, 2019, the filing alleges; six...WW…

Biopharma companies have scrambled to start new R&D projects and repurpose existing medicines amid the COVID-19 crisis. Now, Bayer is donating an older treatment to the U.S. government for potential use.The company is donating 3 million tablets of malaria medicine chloroquine, a decades-old drug that's available for cheap. Axios first news of the donation Wednesday, citing a senior HHS official and another source with knowledge of the plan.Bayer confirmed the donation Thursday.We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more...…Biopharma companies have scrambled to start new R&D projects and repurpose existing medicines amid the COVID-19 crisis. Now, Bayer is donating an older treatment to the U.S. government for potential use.The company is donating 3 million tablets of malaria medicine chloroquine, a decades-old drug that's available for cheap. Axios first news of the donation Wednesday, citing a senior HHS official and another source with knowledge of the plan.Bayer confirmed the donation Thursday.We believe you have the knowledge and expertise to make this year's Veeva 2020 Clinical Operations Report even more...WW…